Corneal Cross-Linking in Pediatric Patients With Progressive Keratoconus

Autor: Martin McCarthy, Paul J. Dubord, Karolien Termote, Stephanie J. Wise, Christian Diaz, Sonia N. Yeung
Přispěvatelé: Ophtalmology - Eye surgery
Rok vydání: 2016
Předmět:
Male
Keratoconus
medicine.medical_specialty
Visual acuity
Distance visual acuity
Adolescent
genetic structures
Visual Acuity/physiology
Ultraviolet Rays
Corneal Stroma
Riboflavin
Visual Acuity
Spherical equivalent
Refraction
Ocular

law.invention
03 medical and health sciences
0302 clinical medicine
law
Ophthalmology
Collagen/metabolism
medicine
Corneal Stroma/metabolism
Humans
Child
Refraction
Ocular/physiology

Retrospective Studies
Medicine(all)
Photosensitizing Agents
Keratometer
business.industry
Keratoconus/drug therapy
Retrospective cohort study
Mean age
Riboflavin/therapeutic use
medicine.disease
eye diseases
Aberrations of the eye
Cross-Linking Reagents
Photochemotherapy
Disease Progression
030221 ophthalmology & optometry
Female
Collagen
sense organs
medicine.symptom
business
030217 neurology & neurosurgery
Zdroj: Cornea. 35:1441-1443
ISSN: 0277-3740
Popis: Purpose To evaluate corneal cross-linking (CXL) in the treatment of keratoconus in pediatric patients. Specifically, this study investigates the impact of CXL on uncorrected distance visual acuity (UDVA), best-corrected distance visual acuity (BDVA), manifest refraction, keratometry (K) measurements, and higher order aberrations. Methods This is a retrospective, observational case series of patients 18 years old or younger with progressive keratoconus who underwent CXL from January 2009 to August 2013. Preoperative and 1-year postoperative data including BDVA, manifest refraction, mean K readings, and corneal aberration measurements were extracted from clinical charts and topographical imaging. Visual acuity was converted to logarithm of the minimum angle of resolution (logMAR) scale, and mean refractive spherical equivalent (MRSE) was calculated from manifest refraction. Results The group consisted of 39 eyes from 28 patients, including 21 males and 7 females (mean age = 16.3 years, range: 11-18, standard deviation [SD] = 1.81). UDVA did not change significantly (preoperative UDVA = 1.20 logMAR, SD = 0.57, and postoperative UDVA = 0.90 logMAR, SD = 0.67, P = 0.19). BDVA did not change significantly (preoperative BDVA = 0.34 logMAR, SD = 0.27, and postoperative BDVA = 0.34 logMAR, SD = 0.23, P = 0.50). There was no significant change in mean K (preoperative K = 48.49, SD = 5.44, and postoperative K = 48.25, SD = 4.74, P = 0.34). Mean MRSE did not change significantly (preoperative MRSE = -3.29 D, SD = 4.04, and postoperative MRSE = -3.53 D, SD = 4.07, P = 0.31). Corneal aberration measurements were available for 10 eyes, and stability of measurements was demonstrated. There were no complications noted. Conclusions This study suggests that CXL is a safe and effective procedure that halts the progression of keratoconus in pediatric patients at 1-year follow-up. To validate these findings, longer follow-up is required.
Databáze: OpenAIRE